The treatments for cervical cancer depend on its severity and type. For carcinoma in situ, or very early cancer, your doctor may kill the malignant growth through cryosurgery, laser surgery, ...

Brachytherapy Awareness Day highlights the value of this precise form of internal radiotherapy in treating cancer. Organised by several oncology organisations, the initiative showcases evidence that ...

A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.

Medicare data show older women with vulvar lichen sclerosus are over 11 times more likely to develop vulvar squamous cell carcinoma or carcinoma in situ.

Cervical cancer is one of the most common gynecologic cancers worldwide and continues to be a leading cause of cancer-related ...

Cervical Adenocarcinoma and Related Neoplasms Publication Trend The graph below shows the total number of publications each year in Cervical Adenocarcinoma and Related Neoplasms.

Tislelizumab combined with chemotherapy shows promising antitumor activity in advanced cervical cancer, achieving high response rates and manageable safety profiles.

Synchronous twin malignancies, defined as the simultaneous occurrence of two distinct primary cancers in the same patient, ...